Acadia Healthcare Company, Inc. (FRA:7RA)
Germany · Delayed Price · Currency is EUR | Market Cap | 2.62B +40.4% |
| Revenue (ttm) | 2.95B +4.3% |
| Net Income | -985.80M |
| EPS | -11.11 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 18.72 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 27.60 |
| Previous Close | 26.80 |
| Day's Range | 27.60 - 27.60 |
| 52-Week Range | 9.65 - 30.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Acadia Healthcare Company
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company owns and operates acute inpatient psychiatric facilities; specialty treatment facilities comprising residential recovery facilities and eating disorder facilities; comprehensive treatment centers; and residential treatment centers, as well as facilities providing outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and i... [Read more]
News
Did Acadia Healthcare Company, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
Acadia Healthcare Announces Date for Third Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its third quarter 2026 results on Wednesday, November 4, 2026, after the close of ...
Acadia Healthcare downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Acadia Healthcare (ACHC) to Outperform from Strong Buy with a $39 price target The reflects limited near-term visibility into PLGL accrual dynamics rather than reduced confide...
Acadia Healthcare downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Acadia Healthcare (ACHC) to Outperform from Strong Buy with an unchanged price target of $39.
Acadia Healthcare Provides Notice of Proposed Derivative Action Settlement
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) issues the below summary notice of proposed settlement as provided for in the September 1, ...
Acadia Healthcare price target raised to $33 from $30 at Leerink
Leerink analyst Whit Mayo raised the firm’s price target on Acadia Healthcare (ACHC) to $33 from $30 and keeps a Market Perform rating on the shares. The firm is fine…
Acadia Healthcare Company Transcript: 2026 Jefferies Healthcare Services and Technology Conference
Strong demand and stable revenue trends are driving growth, with management confident in achieving $200 million incremental EBITDA from new beds and operational improvements. Facility ramp-up, disciplined cost management, and stable labor conditions support positive momentum.
Acadia Healthcare to Participate in 2026 Jefferies Healthcare Services and Technology Conference
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the 2026 Jefferies Healthcare Services and Tech...
Acadia Healthcare Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Acadia Healthcare Company, Inc. - ACHC
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigat...
Robbins LLP Notifies Acadia Healthcare (ACHC) Investors that the Lawsuit Survived Defendants' Motion to Dismiss - Contact Robbins LLP for Information
SAN DIEGO, July 31, 2026 /PRNewswire/ -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to pro...
Acadia Healthcare price target raised to $39 from $38 at Guggenheim
Guggenheim analyst Jason Cassorla raised the firm’s price target on Acadia Healthcare (ACHC) to $39 from $38 and keeps a Buy rating on the shares. After Acadia reported core EBITDA…
Acadia Healthcare price target raised to $32 from $25 at Barclays
Barclays raised the firm’s price target on Acadia Healthcare (ACHC) to $32 from $25 and keeps an Equal Weight rating on the shares post the Q2 report. The company’s “beat-and-raise”…
Acadia Healthcare price target raised to $14.50 from $13 at BofA
BofA raised the firm’s price target on Acadia Healthcare (ACHC) to $14.50 from $13 and keeps an Underperform rating on the shares. The firm attributes it raised target to raised…
Acadia Healthcare Company Earnings Call Transcript: Q2 2026
Second quarter results met or exceeded guidance, with strong free cash flow, disciplined capital deployment, and accelerated ramp-up at new facilities. Revenue was flat year-over-year but grew 2.8% after normalizing for supplemental payments. Leadership changes and operational focus are driving improved execution.
Acadia Healthcare Company Quarterly report: Q2 2026
Acadia Healthcare Company has published its Q2 2026 quarterly earnings report on July 29, 2026.
Acadia Healthcare Company Earnings release: Q2 2026
Acadia Healthcare Company released its Q2 2026 earnings on July 29, 2026, summarizing the period's financial results.
Acadia Healthcare Company Slides: Q2 2026
Acadia Healthcare Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 29, 2026.
Acadia Healthcare’s PLGL headwind offsets DPP benefit, says Cantor Fitzgerald
Acadia Healthcare (ACHC) raised 2026 EBITDA guidance on DPP upside, but an unexpected increase in professional and general liability reserves created a near-term earnings headwind and likely pressure ...
Acadia Healthcare Announces Second Quarter 2026 Results and Updates Full Year 2026 Financial and Cash Flow Guidance
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the second quarter ended June 30, 2026. Second Quarte...
Acadia Healthcare (NASDAQ: ACHC) Investors: Court Denies Motion to Dismiss Paving Way for Litigation to Proceed; Contact Robbins LLP for Information About Your Rights
SAN DIEGO--(BUSINESS WIRE)---- $ACHC #Medicine--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC)...
Acadia Healthcare price target raised to $38 from $31 at Guggenheim
Guggenheim analyst Jason Cassorla raised the firm’s price target on Acadia Healthcare (ACHC) to $38 from $31 and keeps a Buy rating on the shares. The firm updated its Q2…
Acadia Healthcare price target raised to $36 from $30 at TD Cowen
TD Cowen analyst Ryan Langston raised the firm’s price target on Acadia Healthcare (ACHC) to $36 from $30 and keeps a Buy rating on the shares. The firm adjusted targets…
Acadia Healthcare price target raised to $40 from $30 at KeyBanc
KeyBanc raised the firm’s price target on Acadia Healthcare (ACHC) to $40 from $30 and keeps an Overweight rating on the shares. Healthcare utilization continued to moderate through the first…
Acadia Healthcare Announces Date for Second Quarter 2026 Earnings Release
FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the ...
Acadia Healthcare price target raised to $39 from $31 at UBS
UBS raised the firm’s price target on Acadia Healthcare (ACHC) to $39 from $31 and keeps a Buy rating on the shares.